Eris Lifesciences Limited (ERIS)
ISIN: INE406M01024 Industry: Drug Manufacturers—Specialty & Generic Sector: Healthcare Website
678.7
-31.85(-4.48%)

Eris Lifesciences Limited manufactures, markets, and distributes pharmaceutical products in India. It offers various branded formulations in various therapeutic areas, such as cardiovascular, anti–diabetes, anti-infective, antipyretics, vitamins/nutrients, gastroenterology, acute and chronic respiratory, gynecology, pediatrics, neurology, psychiatry, arthritis, and pain/analgesics, as well as in-vitro fertilization, cancer, multi-therapy, cosmetology, and dermatology. The company has an in-licensing partnership with Microlife to offer a range of medical devices comprising blood pressure monitors, blood glucose monitors, infra-red thermometers, nebulizers, and pregnancy testing kits under the CIRCA brand. Eris Lifesciences Limited was incorporated in 2007 and is based in Ahmedabad, India.

Pricing Updates

TODAY'S HIGH

721.4

TODAY'S LOW

675

52 WEEK HIGH

863

52 WEEK LOW

623.05

Major Holders

% of Shares Held by
All Insider

78.94%

% of Shares Held by
Institutions

13.67%

% of Float Held by
Institutions

64.91%

Number of Institutions
Holding Shares

32

Company Overview

MARKET CAP

9262.89 Cr.

ETERPRISE VALUE

9606.41 Cr.

NO. OF SHARES

13.59 Cr.

BOOK VALUE

140.457

DIV. YIELD

6.01%

DEBT

96.61 Cr.

GROSS PROFIT

1067.65 Cr.

CASH

219.36 Cr.

REVENUE

1326.16 Cr.

REVENUE/SHARE

97.606

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Investments0-294.63 Cr.287.99 Cr.34.96 Cr.
Change To Liabilities02.56 Cr.15.93 Cr.-6.65 Cr.
Total cashflows from Investing Activities0-323.35 Cr.123.23 Cr.-5.05 Cr.
Net Borrowings0-5.93 Cr.-184.11 Cr.-200.21 Cr.
Total Cash from Financing Activities0-82.39 Cr.-334.59 Cr.-221.05 Cr.
Other Liabilities011.85 Cr.-6.97 Cr.-11.82 Cr.
Total Assets00089.20 Lakhs
Net Income0355.13 Cr.296.49 Cr.290.79 Cr.
Change in Cash0-30.39 Cr.59.80 Cr.-3.10 Cr.
Effect of Exchange Rate0000
Total Cash from Operating Activities0375.36 Cr.271.16 Cr.222.99 Cr.
Depreciation042.30 Cr.49.85 Cr.36.05 Cr.
Other Cashflows from Investing Activities0-4 Lakhs1.29 Cr.8.56 Cr.
Dividends Paid0-74.67 Cr.-38.96 Cr.-38.96 Cr.
Change to Inventory0-24.99 Cr.13.17 Cr.-17.20 Cr.
Change to Account Receivables015.89 Cr.-74.78 Cr.-17.55 Cr.
Other Cashflows from Financing Activities0-1.78 Cr.-11.51 Cr.-21.73 Cr.
Change to Net Income0-28.08 Cr.-22.93 Cr.-50.91 Cr.
Capital Expenditures0-25.76 Cr.-151.28 Cr.-38 Cr.

Financials

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Research DevelopmentNoneNoneNoneNone
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax0394.49 Cr.331.35 Cr.317.35 Cr.
Minority Interest020 k20 k18.31 Cr.
Net Income420.25 Cr.387.60 Cr.321.85 Cr.308.88 Cr.
Selling General Administrative0243.91 Cr.231.68 Cr.245.29 Cr.
Gross Profit1067.65 Cr.950.71 Cr.882.91 Cr.809.58 Cr.
Ebit420.25 Cr.387.60 Cr.321.85 Cr.308.88 Cr.
Operating Income420.25 Cr.387.60 Cr.321.85 Cr.308.88 Cr.
Other Operating Expenses330.44 Cr.276.20 Cr.279.12 Cr.219.05 Cr.
Interest Expense0-1.80 Cr.-2.16 Cr.-22.89 Cr.
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense039.36 Cr.34.84 Cr.26.21 Cr.
Total Revenue1326.16 Cr.1192.64 Cr.1058.18 Cr.967.20 Cr.
Total Operating Expenses905.91 Cr.805.03 Cr.736.33 Cr.658.32 Cr.
Cost of Revenue0241.93 Cr.175.26 Cr.157.61 Cr.
Total Other Income Expense Net26.09 Cr.6.88 Cr.9.49 Cr.8.47 Cr.
Discontinued OperationsNoneNoneNoneNone
Net Income from Continuous Ops.0355.13 Cr.296.50 Cr.291.14 Cr.
Net Income Applicable to Common Shares0355.13 Cr.296.49 Cr.290.79 Cr.

Balance Sheet

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Intangible Assets0684.07 Cr.698.46 Cr.613.60 Cr.
Capital Surplus0001.34 Cr.
Total Liabilities0258.35 Cr.255.97 Cr.384.83 Cr.
Stock Holder Equity01576.42 Cr.1296.33 Cr.1150.51 Cr.
Minority Interest020 k018.31 Cr.
Other Liabilities65.64 Cr.34.23 Cr.30.61 Cr.20.02 Cr.
Total Assets01834.78 Cr.1552.30 Cr.1553.66 Cr.
Common Stock013.57 Cr.13.57 Cr.13.75 Cr.
Retained Earnings01550.31 Cr.1271.34 Cr.1134.22 Cr.
Other Liabilities086.97 Cr.85.13 Cr.79 Cr.
Good Will093.47 Cr.93.47 Cr.93.58 Cr.
Treasury Stock012.53 Cr.11.41 Cr.1.19 Cr.
Other Assets274.54 Cr.226.39 Cr.190.26 Cr.167.70 Cr.
Cash036.91 Cr.67.30 Cr.7.50 Cr.
Current Liabilities0166.93 Cr.164.69 Cr.305.53 Cr.
Long Term Asset Charges0200.63 Cr.170.91 Cr.144.79 Cr.
Short Long Term Debt000176.13 Cr.
Other Stockholder Equity012.53 Cr.11.41 Cr.1.19 Cr.
Property Plant Equipment077.87 Cr.87.27 Cr.56.07 Cr.
Total Cur. Assets0467.04 Cr.479.61 Cr.581.77 Cr.
Long Term Investments425.34 Cr.285.91 Cr.3.20 Cr.40.91 Cr.
Net Tangible Assets0798.87 Cr.504.39 Cr.443.32 Cr.
Short Term Investments167.03 Cr.92.42 Cr.20 k20 k
Net Receivables0172.53 Cr.206.90 Cr.136.80 Cr.
Long Term Debt00029.30 Lakhs
Inventory094.46 Cr.69.47 Cr.82.65 Cr.
Accounts Payable0102.61 Cr.100.05 Cr.84.12 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account